Side effects of immunotherapy: what to look for and when?

Julie Brahmer

Julie Brahmer, M.D., is interviewed at the ASCO 2016 meeting.

Julie Brahmer, M.D., director of the Thoracic Oncology Program, began treating patients with immunotherapy drugs nearly a decade ago. She led one of the first large studies of the popular drugs, which was reported in 2012. Since then, Brahmer, a program leader in the Bloomberg-Kimmel Institute for Cancer Immunotherapy, has become an expert in identifying and managing side effects that come with taking the drugs. “Patients can experience side effects that include anything that ends in –itis,” says Brahmer. They are typically ones that involve inflammation, such as colitis (inflammation of the colon) and the worst of them, pneumonitis (inflammation of the lungs). These types of side effects aren’t unexpected, says Brahmer, when taking medicines that tinker with the immune system, and inflammation is considered an immune-related biochemical process. Aside from inflammation-related side effects, fatigue often tops the list of the drugs’ side effects, says Brahmer. She says some patients also experience low thyroid hormone levels. A new study of patients receiving immunotherapy at the Kimmel Cancer Center may reveal a connection between the drugs and the development of inflammatory arthritis.

“Patients are concerned about drugs’ side effects,” says Brahmer. “So, we need to educate clinicians and learn to recognize and treat side effects early.” The toxic effects of the drugs can occur anytime during a patient’s regimen, she says, even after patients stop taking the drugs. If side effects occur, they are typically at low grade levels, but some have more severe effects. Treatment includes oral corticosteroids, and, for severe problems, hospitalizations may be necessary.

VN:F [1.9.17_1161]
Rating: 0.0/5 (0 votes cast)
7 Comments

{ 7 comments… read them below or add one }

Comments

Holly McPherson January 1, 2017 at 12:55 am

My husband starts cetuxiban Monday since he has only one kidney Drs changed it from Cistaplain? Is this as effective in ridding his body of the cancer cells, and what are the side effects of it? Thanks so much. Holly

Reply

Vanessa Wasta January 13, 2017 at 9:30 am

Hello Holly,
We're sorry for the delay in our response. While cetuximab is not an immunotherapy drug, we can point you to information about the drug, including side effects, from the National Library of Medicine: https://medlineplus.gov/druginfo/meds/a607041.html. Your husband should keep in close contact with your health care team about his care, including concern about side effects.

We hope this is helpful,
Vanessa Wasta
Office of Public Affairs
Johns Hopkins Kimmel Cancer Center

Reply

erin pettit June 29, 2016 at 7:02 pm

my husband doing immuno at FCCC in Phila does get tired and last blood work showed decrease tsh his was 1.75 now 0.541 he works still has been tired more his is in a clinical trial opdivo/yervoy the last scan showed good /stable he dx lung ca thanks for article

Reply

Gus Damian June 29, 2016 at 5:02 am

What is the current state of immunotherapy involving pancreatic cancer? Thank you!

Reply

Vanessa Wasta June 30, 2016 at 9:51 am

Hello and thank you for your question. You can read more about Johns Hopkins research on immunotherapy for pancreatic cancer in this article (section called First There Were Vaccines): http://www.hopkinsmedicine.org/news/publications/promise_progress/promise__progress_special_issue_bloomberg___kimmel_institute_for_cancer_immunotherapy/the_final_frontier_immune_therapies_break_through_cancers_protective_barriers
We hope this information is helpful,
Vanessa

Reply

Darlene Slarb June 28, 2016 at 11:58 am

Does immunotherapy work on kidney cancer? My husband had left kidney removed over 3 years ago. No other treatment. Cancer has now returned to pancreas. He is scheduled for first on two surgeries this month. Second one will be in 3 months. I am concerned that if he has no other treatment, it will return. Thank you

Reply

Vanessa Wasta June 28, 2016 at 12:20 pm

Hello Darlene - Read this news release from the FDA on an immunotherapy drug for kidney cancer: http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm473971.htm. If you are interested in medical advice from an oncologist at the Johns Hopkins Kimmel Cancer Center, please call 410-955-8964 to make an appointment. We are located in Baltimore, Maryland. Thank you, Vanessa Wasta, Office of Public Affairs, Johns Hopkins Kimmel Cancer Center

Reply

Leave a Comment

You can use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <s> <strike> <strong>

Johns Hopkins Medicine does not necessarily endorse, nor does Johns Hopkins Medicine edit or control, the content of posted comments by third parties on this website. However, Johns Hopkins Medicine reserves the right to remove any such postings that come to the attention of Johns Hopkins Medicine which are deemed to contain objectionable or inappropriate content. Read our Commenting Disclaimer.

Previous post:

Next post: